Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 2Unknown 1Terminated 1Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Neoplasms 6Hematologic Neoplasms 5Breast Neoplasms 4Urinary Bladder Neoplasms 3Pancreatic Neoplasms 3Ovarian Neoplasms 3Lung Neoplasms 3Leukemia, Myeloid, Acute 3Glioma 3Colorectal Neoplasms 3Prostatic Neoplasms 2Neoplasms by Site 2Motor Activity 2Head and Neck Neoplasms 2Glioblastoma 2Carcinoma, Transitional Cell 2Anxiety Disorders 2Anatomic Stage I Breast Cancer AJCC v8 2Uveal Melanoma 1Uterine Neoplasms 1Urologic Neoplasms 1Urologic Diseases 1Urogenital Neoplasms 1Urinary Bladder Diseases 1Urethral Neoplasms 1Ureteral Neoplasms 1Stomatitis 1Stomach Neoplasms 1Smoking Cessation 1Small Cell Lung Carcinoma 1

Interventions

hydrated silica gel-based toothpaste 1cobiprostone 1clazakizumab 1aluminum hydroxide, magnesium hydroxide, drug combination 1Zinc Sulfate 1Zinc 1Tomography, Optical Coherence 1Surveys and Questionnaires 1Standard of Care 1Spectrometry, Fluorescence 1Sodium Bicarbonate 1Saliva, Artificial 1Saline Solution 1Radiation 1Mannitol 1Lidocaine 1Etanercept 1Drug Therapy 1Diphenhydramine 1Dental Prophylaxis 1Biotene 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Stomatitis × Standard of Care × Clear all
NCT00574860 2013-09-20

EN3285 for the Prevention or Delay of Oral Mucositis in Patients With Head and Neck Cancer

Endo Pharmaceuticals

Phase 3 Terminated
240 enrolled
Head & Neck

Head and Neck Neoplasms, Stomatitis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡